Form EFFECT Cyclacel Pharmaceuticals
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 11, 2025 |
| Accession Number: | 0001641172-25-026154 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Office of Morocco Releases Statement on President Trump's Reaffirmation of U.S. Recognition of Moroccan Sovereignty Over Western Sahara
- Dime City Apparel Hits Major Engagement Milestones Through Its Sub‑Brand, Dime City Pretty, on YouTube Shorts
- New Powersports & Motorcycles Division Launches at Atticus Goods
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share